Global Live Brucellosis Vaccine Market Research Report 2026(Status and Outlook)
Live Brucellosis Vaccine is a kind of vaccine used to prevent brucellosis, which is also known as Malta fever or undulant fever. It is a live attenuated vaccine prepared from weakened strains of Brucella bacteria. The attenuated Brucella strains in the live vaccine still retain certain antigenicity, which can stimulate the body's immune system to produce a relatively strong immune response, inducing the production of specific antibodies and cell-mediated immune responses, thereby providing effective protection for the body to prevent the occurrence of brucellosis. The attenuated strains in the live vaccine can replicate to a limited extent in the body, allowing the body's immune system to be continuously stimulated by antigens, resulting in more long-lasting immunity and extending the duration of immune protection.
The global Live Brucellosis Vaccine market size was estimated at USD 193.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.20% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Live Brucellosis Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Live Brucellosis Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Live Brucellosis Vaccine market.
Global Live Brucellosis Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
CZ Vaccines
MSD
Ceva
Colorado Serum
Tecnovax
Syva
Shchelkovo Biocombinat
Jinyu Baoling
Biovet
CAVAC
VETAL
Indian Immunologicals
Dollvet
Hester Biosciences
Qilu Animal Health
Auleon Biologicals
Market Segmentation (by Type)
Strain RB-51
Strain S19
Strain S2
Strain A19
Strain Rev. I
Market Segmentation (by Application)
Cattle
Sheep
Pig
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Live Brucellosis Vaccine Market
Overview of the regional outlook of the Live Brucellosis Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Live Brucellosis Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Live Brucellosis Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Live Brucellosis Vaccine market size was estimated at USD 193.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.20% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Live Brucellosis Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Live Brucellosis Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Live Brucellosis Vaccine market.
Global Live Brucellosis Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
CZ Vaccines
MSD
Ceva
Colorado Serum
Tecnovax
Syva
Shchelkovo Biocombinat
Jinyu Baoling
Biovet
CAVAC
VETAL
Indian Immunologicals
Dollvet
Hester Biosciences
Qilu Animal Health
Auleon Biologicals
Market Segmentation (by Type)
Strain RB-51
Strain S19
Strain S2
Strain A19
Strain Rev. I
Market Segmentation (by Application)
Cattle
Sheep
Pig
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Live Brucellosis Vaccine Market
Overview of the regional outlook of the Live Brucellosis Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Live Brucellosis Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Live Brucellosis Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Live Brucellosis Vaccine
1.2 Key Market Segments
1.2.1 Live Brucellosis Vaccine Segment by Type
1.2.2 Live Brucellosis Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LIVE BRUCELLOSIS VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Live Brucellosis Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Live Brucellosis Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LIVE BRUCELLOSIS VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Live Brucellosis Vaccine Product Life Cycle
3.3 Global Live Brucellosis Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Live Brucellosis Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Live Brucellosis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Live Brucellosis Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Live Brucellosis Vaccine Market Competitive Situation and Trends
3.8.1 Live Brucellosis Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Live Brucellosis Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 LIVE BRUCELLOSIS VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Live Brucellosis Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LIVE BRUCELLOSIS VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Live Brucellosis Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Live Brucellosis Vaccine Market
5.7 ESG Ratings of Leading Companies
6 LIVE BRUCELLOSIS VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Live Brucellosis Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Live Brucellosis Vaccine Market Size by Type (2020-2025)
6.4 Global Live Brucellosis Vaccine Price by Type (2020-2025)
7 LIVE BRUCELLOSIS VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Live Brucellosis Vaccine Market Sales by Application (2020-2025)
7.3 Global Live Brucellosis Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Live Brucellosis Vaccine Sales Growth Rate by Application (2020-2025)
8 LIVE BRUCELLOSIS VACCINE MARKET SALES BY REGION
8.1 Global Live Brucellosis Vaccine Sales by Region
8.1.1 Global Live Brucellosis Vaccine Sales by Region
8.1.2 Global Live Brucellosis Vaccine Sales Market Share by Region
8.2 Global Live Brucellosis Vaccine Market Size by Region
8.2.1 Global Live Brucellosis Vaccine Market Size by Region
8.2.2 Global Live Brucellosis Vaccine Market Size by Region
8.3 North America
8.3.1 North America Live Brucellosis Vaccine Sales by Country
8.3.2 North America Live Brucellosis Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Live Brucellosis Vaccine Sales by Country
8.4.2 Europe Live Brucellosis Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Live Brucellosis Vaccine Sales by Region
8.5.2 Asia Pacific Live Brucellosis Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Live Brucellosis Vaccine Sales by Country
8.6.2 South America Live Brucellosis Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Live Brucellosis Vaccine Sales by Region
8.7.2 Middle East and Africa Live Brucellosis Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 LIVE BRUCELLOSIS VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Live Brucellosis Vaccine by Region(2020-2025)
9.2 Global Live Brucellosis Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Live Brucellosis Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Live Brucellosis Vaccine Production
9.4.1 North America Live Brucellosis Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Live Brucellosis Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Live Brucellosis Vaccine Production
9.5.1 Europe Live Brucellosis Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Live Brucellosis Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Live Brucellosis Vaccine Production (2020-2025)
9.6.1 Japan Live Brucellosis Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Live Brucellosis Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Live Brucellosis Vaccine Production (2020-2025)
9.7.1 China Live Brucellosis Vaccine Production Growth Rate (2020-2025)
9.7.2 China Live Brucellosis Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 CZ Vaccines
10.1.1 CZ Vaccines Basic Information
10.1.2 CZ Vaccines Live Brucellosis Vaccine Product Overview
10.1.3 CZ Vaccines Live Brucellosis Vaccine Product Market Performance
10.1.4 CZ Vaccines Business Overview
10.1.5 CZ Vaccines SWOT Analysis
10.1.6 CZ Vaccines Recent Developments
10.2 MSD
10.2.1 MSD Basic Information
10.2.2 MSD Live Brucellosis Vaccine Product Overview
10.2.3 MSD Live Brucellosis Vaccine Product Market Performance
10.2.4 MSD Business Overview
10.2.5 MSD SWOT Analysis
10.2.6 MSD Recent Developments
10.3 Ceva
10.3.1 Ceva Basic Information
10.3.2 Ceva Live Brucellosis Vaccine Product Overview
10.3.3 Ceva Live Brucellosis Vaccine Product Market Performance
10.3.4 Ceva Business Overview
10.3.5 Ceva SWOT Analysis
10.3.6 Ceva Recent Developments
10.4 Colorado Serum
10.4.1 Colorado Serum Basic Information
10.4.2 Colorado Serum Live Brucellosis Vaccine Product Overview
10.4.3 Colorado Serum Live Brucellosis Vaccine Product Market Performance
10.4.4 Colorado Serum Business Overview
10.4.5 Colorado Serum Recent Developments
10.5 Tecnovax
10.5.1 Tecnovax Basic Information
10.5.2 Tecnovax Live Brucellosis Vaccine Product Overview
10.5.3 Tecnovax Live Brucellosis Vaccine Product Market Performance
10.5.4 Tecnovax Business Overview
10.5.5 Tecnovax Recent Developments
10.6 Syva
10.6.1 Syva Basic Information
10.6.2 Syva Live Brucellosis Vaccine Product Overview
10.6.3 Syva Live Brucellosis Vaccine Product Market Performance
10.6.4 Syva Business Overview
10.6.5 Syva Recent Developments
10.7 Shchelkovo Biocombinat
10.7.1 Shchelkovo Biocombinat Basic Information
10.7.2 Shchelkovo Biocombinat Live Brucellosis Vaccine Product Overview
10.7.3 Shchelkovo Biocombinat Live Brucellosis Vaccine Product Market Performance
10.7.4 Shchelkovo Biocombinat Business Overview
10.7.5 Shchelkovo Biocombinat Recent Developments
10.8 Jinyu Baoling
10.8.1 Jinyu Baoling Basic Information
10.8.2 Jinyu Baoling Live Brucellosis Vaccine Product Overview
10.8.3 Jinyu Baoling Live Brucellosis Vaccine Product Market Performance
10.8.4 Jinyu Baoling Business Overview
10.8.5 Jinyu Baoling Recent Developments
10.9 Biovet
10.9.1 Biovet Basic Information
10.9.2 Biovet Live Brucellosis Vaccine Product Overview
10.9.3 Biovet Live Brucellosis Vaccine Product Market Performance
10.9.4 Biovet Business Overview
10.9.5 Biovet Recent Developments
10.10 CAVAC
10.10.1 CAVAC Basic Information
10.10.2 CAVAC Live Brucellosis Vaccine Product Overview
10.10.3 CAVAC Live Brucellosis Vaccine Product Market Performance
10.10.4 CAVAC Business Overview
10.10.5 CAVAC Recent Developments
10.11 VETAL
10.11.1 VETAL Basic Information
10.11.2 VETAL Live Brucellosis Vaccine Product Overview
10.11.3 VETAL Live Brucellosis Vaccine Product Market Performance
10.11.4 VETAL Business Overview
10.11.5 VETAL Recent Developments
10.12 Indian Immunologicals
10.12.1 Indian Immunologicals Basic Information
10.12.2 Indian Immunologicals Live Brucellosis Vaccine Product Overview
10.12.3 Indian Immunologicals Live Brucellosis Vaccine Product Market Performance
10.12.4 Indian Immunologicals Business Overview
10.12.5 Indian Immunologicals Recent Developments
10.13 Dollvet
10.13.1 Dollvet Basic Information
10.13.2 Dollvet Live Brucellosis Vaccine Product Overview
10.13.3 Dollvet Live Brucellosis Vaccine Product Market Performance
10.13.4 Dollvet Business Overview
10.13.5 Dollvet Recent Developments
10.14 Hester Biosciences
10.14.1 Hester Biosciences Basic Information
10.14.2 Hester Biosciences Live Brucellosis Vaccine Product Overview
10.14.3 Hester Biosciences Live Brucellosis Vaccine Product Market Performance
10.14.4 Hester Biosciences Business Overview
10.14.5 Hester Biosciences Recent Developments
10.15 Qilu Animal Health
10.15.1 Qilu Animal Health Basic Information
10.15.2 Qilu Animal Health Live Brucellosis Vaccine Product Overview
10.15.3 Qilu Animal Health Live Brucellosis Vaccine Product Market Performance
10.15.4 Qilu Animal Health Business Overview
10.15.5 Qilu Animal Health Recent Developments
10.16 Auleon Biologicals
10.16.1 Auleon Biologicals Basic Information
10.16.2 Auleon Biologicals Live Brucellosis Vaccine Product Overview
10.16.3 Auleon Biologicals Live Brucellosis Vaccine Product Market Performance
10.16.4 Auleon Biologicals Business Overview
10.16.5 Auleon Biologicals Recent Developments
11 LIVE BRUCELLOSIS VACCINE MARKET FORECAST BY REGION
11.1 Global Live Brucellosis Vaccine Market Size Forecast
11.2 Global Live Brucellosis Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Live Brucellosis Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Live Brucellosis Vaccine Market Size Forecast by Region
11.2.4 South America Live Brucellosis Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Live Brucellosis Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Live Brucellosis Vaccine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Live Brucellosis Vaccine by Type (2026-2035)
12.1.2 Global Live Brucellosis Vaccine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Live Brucellosis Vaccine by Type (2026-2035)
12.2 Global Live Brucellosis Vaccine Market Forecast by Application (2026-2035)
12.2.1 Global Live Brucellosis Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Live Brucellosis Vaccine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Live Brucellosis Vaccine
1.2 Key Market Segments
1.2.1 Live Brucellosis Vaccine Segment by Type
1.2.2 Live Brucellosis Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LIVE BRUCELLOSIS VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Live Brucellosis Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Live Brucellosis Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LIVE BRUCELLOSIS VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Live Brucellosis Vaccine Product Life Cycle
3.3 Global Live Brucellosis Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Live Brucellosis Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Live Brucellosis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Live Brucellosis Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Live Brucellosis Vaccine Market Competitive Situation and Trends
3.8.1 Live Brucellosis Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Live Brucellosis Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 LIVE BRUCELLOSIS VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Live Brucellosis Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LIVE BRUCELLOSIS VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Live Brucellosis Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Live Brucellosis Vaccine Market
5.7 ESG Ratings of Leading Companies
6 LIVE BRUCELLOSIS VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Live Brucellosis Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Live Brucellosis Vaccine Market Size by Type (2020-2025)
6.4 Global Live Brucellosis Vaccine Price by Type (2020-2025)
7 LIVE BRUCELLOSIS VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Live Brucellosis Vaccine Market Sales by Application (2020-2025)
7.3 Global Live Brucellosis Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Live Brucellosis Vaccine Sales Growth Rate by Application (2020-2025)
8 LIVE BRUCELLOSIS VACCINE MARKET SALES BY REGION
8.1 Global Live Brucellosis Vaccine Sales by Region
8.1.1 Global Live Brucellosis Vaccine Sales by Region
8.1.2 Global Live Brucellosis Vaccine Sales Market Share by Region
8.2 Global Live Brucellosis Vaccine Market Size by Region
8.2.1 Global Live Brucellosis Vaccine Market Size by Region
8.2.2 Global Live Brucellosis Vaccine Market Size by Region
8.3 North America
8.3.1 North America Live Brucellosis Vaccine Sales by Country
8.3.2 North America Live Brucellosis Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Live Brucellosis Vaccine Sales by Country
8.4.2 Europe Live Brucellosis Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Live Brucellosis Vaccine Sales by Region
8.5.2 Asia Pacific Live Brucellosis Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Live Brucellosis Vaccine Sales by Country
8.6.2 South America Live Brucellosis Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Live Brucellosis Vaccine Sales by Region
8.7.2 Middle East and Africa Live Brucellosis Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 LIVE BRUCELLOSIS VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Live Brucellosis Vaccine by Region(2020-2025)
9.2 Global Live Brucellosis Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Live Brucellosis Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Live Brucellosis Vaccine Production
9.4.1 North America Live Brucellosis Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Live Brucellosis Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Live Brucellosis Vaccine Production
9.5.1 Europe Live Brucellosis Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Live Brucellosis Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Live Brucellosis Vaccine Production (2020-2025)
9.6.1 Japan Live Brucellosis Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Live Brucellosis Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Live Brucellosis Vaccine Production (2020-2025)
9.7.1 China Live Brucellosis Vaccine Production Growth Rate (2020-2025)
9.7.2 China Live Brucellosis Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 CZ Vaccines
10.1.1 CZ Vaccines Basic Information
10.1.2 CZ Vaccines Live Brucellosis Vaccine Product Overview
10.1.3 CZ Vaccines Live Brucellosis Vaccine Product Market Performance
10.1.4 CZ Vaccines Business Overview
10.1.5 CZ Vaccines SWOT Analysis
10.1.6 CZ Vaccines Recent Developments
10.2 MSD
10.2.1 MSD Basic Information
10.2.2 MSD Live Brucellosis Vaccine Product Overview
10.2.3 MSD Live Brucellosis Vaccine Product Market Performance
10.2.4 MSD Business Overview
10.2.5 MSD SWOT Analysis
10.2.6 MSD Recent Developments
10.3 Ceva
10.3.1 Ceva Basic Information
10.3.2 Ceva Live Brucellosis Vaccine Product Overview
10.3.3 Ceva Live Brucellosis Vaccine Product Market Performance
10.3.4 Ceva Business Overview
10.3.5 Ceva SWOT Analysis
10.3.6 Ceva Recent Developments
10.4 Colorado Serum
10.4.1 Colorado Serum Basic Information
10.4.2 Colorado Serum Live Brucellosis Vaccine Product Overview
10.4.3 Colorado Serum Live Brucellosis Vaccine Product Market Performance
10.4.4 Colorado Serum Business Overview
10.4.5 Colorado Serum Recent Developments
10.5 Tecnovax
10.5.1 Tecnovax Basic Information
10.5.2 Tecnovax Live Brucellosis Vaccine Product Overview
10.5.3 Tecnovax Live Brucellosis Vaccine Product Market Performance
10.5.4 Tecnovax Business Overview
10.5.5 Tecnovax Recent Developments
10.6 Syva
10.6.1 Syva Basic Information
10.6.2 Syva Live Brucellosis Vaccine Product Overview
10.6.3 Syva Live Brucellosis Vaccine Product Market Performance
10.6.4 Syva Business Overview
10.6.5 Syva Recent Developments
10.7 Shchelkovo Biocombinat
10.7.1 Shchelkovo Biocombinat Basic Information
10.7.2 Shchelkovo Biocombinat Live Brucellosis Vaccine Product Overview
10.7.3 Shchelkovo Biocombinat Live Brucellosis Vaccine Product Market Performance
10.7.4 Shchelkovo Biocombinat Business Overview
10.7.5 Shchelkovo Biocombinat Recent Developments
10.8 Jinyu Baoling
10.8.1 Jinyu Baoling Basic Information
10.8.2 Jinyu Baoling Live Brucellosis Vaccine Product Overview
10.8.3 Jinyu Baoling Live Brucellosis Vaccine Product Market Performance
10.8.4 Jinyu Baoling Business Overview
10.8.5 Jinyu Baoling Recent Developments
10.9 Biovet
10.9.1 Biovet Basic Information
10.9.2 Biovet Live Brucellosis Vaccine Product Overview
10.9.3 Biovet Live Brucellosis Vaccine Product Market Performance
10.9.4 Biovet Business Overview
10.9.5 Biovet Recent Developments
10.10 CAVAC
10.10.1 CAVAC Basic Information
10.10.2 CAVAC Live Brucellosis Vaccine Product Overview
10.10.3 CAVAC Live Brucellosis Vaccine Product Market Performance
10.10.4 CAVAC Business Overview
10.10.5 CAVAC Recent Developments
10.11 VETAL
10.11.1 VETAL Basic Information
10.11.2 VETAL Live Brucellosis Vaccine Product Overview
10.11.3 VETAL Live Brucellosis Vaccine Product Market Performance
10.11.4 VETAL Business Overview
10.11.5 VETAL Recent Developments
10.12 Indian Immunologicals
10.12.1 Indian Immunologicals Basic Information
10.12.2 Indian Immunologicals Live Brucellosis Vaccine Product Overview
10.12.3 Indian Immunologicals Live Brucellosis Vaccine Product Market Performance
10.12.4 Indian Immunologicals Business Overview
10.12.5 Indian Immunologicals Recent Developments
10.13 Dollvet
10.13.1 Dollvet Basic Information
10.13.2 Dollvet Live Brucellosis Vaccine Product Overview
10.13.3 Dollvet Live Brucellosis Vaccine Product Market Performance
10.13.4 Dollvet Business Overview
10.13.5 Dollvet Recent Developments
10.14 Hester Biosciences
10.14.1 Hester Biosciences Basic Information
10.14.2 Hester Biosciences Live Brucellosis Vaccine Product Overview
10.14.3 Hester Biosciences Live Brucellosis Vaccine Product Market Performance
10.14.4 Hester Biosciences Business Overview
10.14.5 Hester Biosciences Recent Developments
10.15 Qilu Animal Health
10.15.1 Qilu Animal Health Basic Information
10.15.2 Qilu Animal Health Live Brucellosis Vaccine Product Overview
10.15.3 Qilu Animal Health Live Brucellosis Vaccine Product Market Performance
10.15.4 Qilu Animal Health Business Overview
10.15.5 Qilu Animal Health Recent Developments
10.16 Auleon Biologicals
10.16.1 Auleon Biologicals Basic Information
10.16.2 Auleon Biologicals Live Brucellosis Vaccine Product Overview
10.16.3 Auleon Biologicals Live Brucellosis Vaccine Product Market Performance
10.16.4 Auleon Biologicals Business Overview
10.16.5 Auleon Biologicals Recent Developments
11 LIVE BRUCELLOSIS VACCINE MARKET FORECAST BY REGION
11.1 Global Live Brucellosis Vaccine Market Size Forecast
11.2 Global Live Brucellosis Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Live Brucellosis Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Live Brucellosis Vaccine Market Size Forecast by Region
11.2.4 South America Live Brucellosis Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Live Brucellosis Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Live Brucellosis Vaccine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Live Brucellosis Vaccine by Type (2026-2035)
12.1.2 Global Live Brucellosis Vaccine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Live Brucellosis Vaccine by Type (2026-2035)
12.2 Global Live Brucellosis Vaccine Market Forecast by Application (2026-2035)
12.2.1 Global Live Brucellosis Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Live Brucellosis Vaccine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Live Brucellosis Vaccine Market Size by Type (M USD)
Table 4. Global Live Brucellosis Vaccine Market Size by Application
Table 5. Live Brucellosis Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Live Brucellosis Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Live Brucellosis Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Live Brucellosis Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Live Brucellosis Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Live Brucellosis Vaccine as of 2025)
Table 11. Global Market Live Brucellosis Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Live Brucellosis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Live Brucellosis Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Live Brucellosis Vaccine Sales by Type (K MT)
Table 27. Global Live Brucellosis Vaccine Market Size by Type (M USD)
Table 28. Global Live Brucellosis Vaccine Sales (K MT) by Type (2020-2025)
Table 29. Global Live Brucellosis Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global Live Brucellosis Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global Live Brucellosis Vaccine Market Share by Type (2020-2025)
Table 32. Global Live Brucellosis Vaccine Price (USD/KG) by Type (2020-2025)
Table 33. Global Live Brucellosis Vaccine Sales (K MT) by Application
Table 34. Global Live Brucellosis Vaccine Market Size by Application
Table 35. Global Live Brucellosis Vaccine Sales by Application (2020-2025) & (K MT)
Table 36. Global Live Brucellosis Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global Live Brucellosis Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Live Brucellosis Vaccine Market Share by Application (2020-2025)
Table 39. Global Live Brucellosis Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global Live Brucellosis Vaccine Sales by Region (2020-2025) & (K MT)
Table 41. Global Live Brucellosis Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global Live Brucellosis Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Live Brucellosis Vaccine Market Size by Region (2020-2025)
Table 44. North America Live Brucellosis Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. North America Live Brucellosis Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Live Brucellosis Vaccine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Live Brucellosis Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Live Brucellosis Vaccine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Live Brucellosis Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Live Brucellosis Vaccine Sales by Country (2020-2025) & (K MT)
Table 51. South America Live Brucellosis Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Live Brucellosis Vaccine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Live Brucellosis Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Live Brucellosis Vaccine Production (K MT) by Region(2020-2025)
Table 55. Global Live Brucellosis Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Live Brucellosis Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global Live Brucellosis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Live Brucellosis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Live Brucellosis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Live Brucellosis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Live Brucellosis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. CZ Vaccines Basic Information
Table 63. CZ Vaccines Live Brucellosis Vaccine Product Overview
Table 64. CZ Vaccines Live Brucellosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. CZ Vaccines Business Overview
Table 66. CZ Vaccines SWOT Analysis
Table 67. CZ Vaccines Recent Developments
Table 68. MSD Basic Information
Table 69. MSD Live Brucellosis Vaccine Product Overview
Table 70. MSD Live Brucellosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. MSD Business Overview
Table 72. MSD SWOT Analysis
Table 73. MSD Recent Developments
Table 74. Ceva Basic Information
Table 75. Ceva Live Brucellosis Vaccine Product Overview
Table 76. Ceva Live Brucellosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Ceva Business Overview
Table 78. Ceva SWOT Analysis
Table 79. Ceva Recent Developments
Table 80. Colorado Serum Basic Information
Table 81. Colorado Serum Live Brucellosis Vaccine Product Overview
Table 82. Colorado Serum Live Brucellosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Colorado Serum Business Overview
Table 84. Colorado Serum Recent Developments
Table 85. Tecnovax Basic Information
Table 86. Tecnovax Live Brucellosis Vaccine Product Overview
Table 87. Tecnovax Live Brucellosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Tecnovax Business Overview
Table 89. Tecnovax Recent Developments
Table 90. Syva Basic Information
Table 91. Syva Live Brucellosis Vaccine Product Overview
Table 92. Syva Live Brucellosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Syva Business Overview
Table 94. Syva Recent Developments
Table 95. Shchelkovo Biocombinat Basic Information
Table 96. Shchelkovo Biocombinat Live Brucellosis Vaccine Product Overview
Table 97. Shchelkovo Biocombinat Live Brucellosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Shchelkovo Biocombinat Business Overview
Table 99. Shchelkovo Biocombinat Recent Developments
Table 100. Jinyu Baoling Basic Information
Table 101. Jinyu Baoling Live Brucellosis Vaccine Product Overview
Table 102. Jinyu Baoling Live Brucellosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Jinyu Baoling Business Overview
Table 104. Jinyu Baoling Recent Developments
Table 105. Biovet Basic Information
Table 106. Biovet Live Brucellosis Vaccine Product Overview
Table 107. Biovet Live Brucellosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Biovet Business Overview
Table 109. Biovet Recent Developments
Table 110. CAVAC Basic Information
Table 111. CAVAC Live Brucellosis Vaccine Product Overview
Table 112. CAVAC Live Brucellosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. CAVAC Business Overview
Table 114. CAVAC Recent Developments
Table 115. VETAL Basic Information
Table 116. VETAL Live Brucellosis Vaccine Product Overview
Table 117. VETAL Live Brucellosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. VETAL Business Overview
Table 119. VETAL Recent Developments
Table 120. Indian Immunologicals Basic Information
Table 121. Indian Immunologicals Live Brucellosis Vaccine Product Overview
Table 122. Indian Immunologicals Live Brucellosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Indian Immunologicals Business Overview
Table 124. Indian Immunologicals Recent Developments
Table 125. Dollvet Basic Information
Table 126. Dollvet Live Brucellosis Vaccine Product Overview
Table 127. Dollvet Live Brucellosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Dollvet Business Overview
Table 129. Dollvet Recent Developments
Table 130. Hester Biosciences Basic Information
Table 131. Hester Biosciences Live Brucellosis Vaccine Product Overview
Table 132. Hester Biosciences Live Brucellosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Hester Biosciences Business Overview
Table 134. Hester Biosciences Recent Developments
Table 135. Qilu Animal Health Basic Information
Table 136. Qilu Animal Health Live Brucellosis Vaccine Product Overview
Table 137. Qilu Animal Health Live Brucellosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Qilu Animal Health Business Overview
Table 139. Qilu Animal Health Recent Developments
Table 140. Auleon Biologicals Basic Information
Table 141. Auleon Biologicals Live Brucellosis Vaccine Product Overview
Table 142. Auleon Biologicals Live Brucellosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Auleon Biologicals Business Overview
Table 144. Auleon Biologicals Recent Developments
Table 145. Global Live Brucellosis Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 146. Global Live Brucellosis Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 147. North America Live Brucellosis Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 148. North America Live Brucellosis Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 149. Europe Live Brucellosis Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 150. Europe Live Brucellosis Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 151. Asia Pacific Live Brucellosis Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 152. Asia Pacific Live Brucellosis Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 153. South America Live Brucellosis Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 154. South America Live Brucellosis Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 155. Middle East and Africa Live Brucellosis Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 156. Middle East and Africa Live Brucellosis Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 157. Global Live Brucellosis Vaccine Sales Forecast by Type (2026-2035) & (K MT)
Table 158. Global Live Brucellosis Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 159. Global Live Brucellosis Vaccine Price Forecast by Type (2026-2035) & (USD/KG)
Table 160. Global Live Brucellosis Vaccine Sales (K MT) Forecast by Application (2026-2035)
Table 161. Global Live Brucellosis Vaccine Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Live Brucellosis Vaccine Market Size by Type (M USD)
Table 4. Global Live Brucellosis Vaccine Market Size by Application
Table 5. Live Brucellosis Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Live Brucellosis Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Live Brucellosis Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Live Brucellosis Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Live Brucellosis Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Live Brucellosis Vaccine as of 2025)
Table 11. Global Market Live Brucellosis Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Live Brucellosis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Live Brucellosis Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Live Brucellosis Vaccine Sales by Type (K MT)
Table 27. Global Live Brucellosis Vaccine Market Size by Type (M USD)
Table 28. Global Live Brucellosis Vaccine Sales (K MT) by Type (2020-2025)
Table 29. Global Live Brucellosis Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global Live Brucellosis Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global Live Brucellosis Vaccine Market Share by Type (2020-2025)
Table 32. Global Live Brucellosis Vaccine Price (USD/KG) by Type (2020-2025)
Table 33. Global Live Brucellosis Vaccine Sales (K MT) by Application
Table 34. Global Live Brucellosis Vaccine Market Size by Application
Table 35. Global Live Brucellosis Vaccine Sales by Application (2020-2025) & (K MT)
Table 36. Global Live Brucellosis Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global Live Brucellosis Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Live Brucellosis Vaccine Market Share by Application (2020-2025)
Table 39. Global Live Brucellosis Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global Live Brucellosis Vaccine Sales by Region (2020-2025) & (K MT)
Table 41. Global Live Brucellosis Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global Live Brucellosis Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Live Brucellosis Vaccine Market Size by Region (2020-2025)
Table 44. North America Live Brucellosis Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. North America Live Brucellosis Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Live Brucellosis Vaccine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Live Brucellosis Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Live Brucellosis Vaccine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Live Brucellosis Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Live Brucellosis Vaccine Sales by Country (2020-2025) & (K MT)
Table 51. South America Live Brucellosis Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Live Brucellosis Vaccine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Live Brucellosis Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Live Brucellosis Vaccine Production (K MT) by Region(2020-2025)
Table 55. Global Live Brucellosis Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Live Brucellosis Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global Live Brucellosis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Live Brucellosis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Live Brucellosis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Live Brucellosis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Live Brucellosis Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. CZ Vaccines Basic Information
Table 63. CZ Vaccines Live Brucellosis Vaccine Product Overview
Table 64. CZ Vaccines Live Brucellosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. CZ Vaccines Business Overview
Table 66. CZ Vaccines SWOT Analysis
Table 67. CZ Vaccines Recent Developments
Table 68. MSD Basic Information
Table 69. MSD Live Brucellosis Vaccine Product Overview
Table 70. MSD Live Brucellosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. MSD Business Overview
Table 72. MSD SWOT Analysis
Table 73. MSD Recent Developments
Table 74. Ceva Basic Information
Table 75. Ceva Live Brucellosis Vaccine Product Overview
Table 76. Ceva Live Brucellosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Ceva Business Overview
Table 78. Ceva SWOT Analysis
Table 79. Ceva Recent Developments
Table 80. Colorado Serum Basic Information
Table 81. Colorado Serum Live Brucellosis Vaccine Product Overview
Table 82. Colorado Serum Live Brucellosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Colorado Serum Business Overview
Table 84. Colorado Serum Recent Developments
Table 85. Tecnovax Basic Information
Table 86. Tecnovax Live Brucellosis Vaccine Product Overview
Table 87. Tecnovax Live Brucellosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Tecnovax Business Overview
Table 89. Tecnovax Recent Developments
Table 90. Syva Basic Information
Table 91. Syva Live Brucellosis Vaccine Product Overview
Table 92. Syva Live Brucellosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Syva Business Overview
Table 94. Syva Recent Developments
Table 95. Shchelkovo Biocombinat Basic Information
Table 96. Shchelkovo Biocombinat Live Brucellosis Vaccine Product Overview
Table 97. Shchelkovo Biocombinat Live Brucellosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Shchelkovo Biocombinat Business Overview
Table 99. Shchelkovo Biocombinat Recent Developments
Table 100. Jinyu Baoling Basic Information
Table 101. Jinyu Baoling Live Brucellosis Vaccine Product Overview
Table 102. Jinyu Baoling Live Brucellosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Jinyu Baoling Business Overview
Table 104. Jinyu Baoling Recent Developments
Table 105. Biovet Basic Information
Table 106. Biovet Live Brucellosis Vaccine Product Overview
Table 107. Biovet Live Brucellosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Biovet Business Overview
Table 109. Biovet Recent Developments
Table 110. CAVAC Basic Information
Table 111. CAVAC Live Brucellosis Vaccine Product Overview
Table 112. CAVAC Live Brucellosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. CAVAC Business Overview
Table 114. CAVAC Recent Developments
Table 115. VETAL Basic Information
Table 116. VETAL Live Brucellosis Vaccine Product Overview
Table 117. VETAL Live Brucellosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. VETAL Business Overview
Table 119. VETAL Recent Developments
Table 120. Indian Immunologicals Basic Information
Table 121. Indian Immunologicals Live Brucellosis Vaccine Product Overview
Table 122. Indian Immunologicals Live Brucellosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Indian Immunologicals Business Overview
Table 124. Indian Immunologicals Recent Developments
Table 125. Dollvet Basic Information
Table 126. Dollvet Live Brucellosis Vaccine Product Overview
Table 127. Dollvet Live Brucellosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Dollvet Business Overview
Table 129. Dollvet Recent Developments
Table 130. Hester Biosciences Basic Information
Table 131. Hester Biosciences Live Brucellosis Vaccine Product Overview
Table 132. Hester Biosciences Live Brucellosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Hester Biosciences Business Overview
Table 134. Hester Biosciences Recent Developments
Table 135. Qilu Animal Health Basic Information
Table 136. Qilu Animal Health Live Brucellosis Vaccine Product Overview
Table 137. Qilu Animal Health Live Brucellosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Qilu Animal Health Business Overview
Table 139. Qilu Animal Health Recent Developments
Table 140. Auleon Biologicals Basic Information
Table 141. Auleon Biologicals Live Brucellosis Vaccine Product Overview
Table 142. Auleon Biologicals Live Brucellosis Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Auleon Biologicals Business Overview
Table 144. Auleon Biologicals Recent Developments
Table 145. Global Live Brucellosis Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 146. Global Live Brucellosis Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 147. North America Live Brucellosis Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 148. North America Live Brucellosis Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 149. Europe Live Brucellosis Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 150. Europe Live Brucellosis Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 151. Asia Pacific Live Brucellosis Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 152. Asia Pacific Live Brucellosis Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 153. South America Live Brucellosis Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 154. South America Live Brucellosis Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 155. Middle East and Africa Live Brucellosis Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 156. Middle East and Africa Live Brucellosis Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 157. Global Live Brucellosis Vaccine Sales Forecast by Type (2026-2035) & (K MT)
Table 158. Global Live Brucellosis Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 159. Global Live Brucellosis Vaccine Price Forecast by Type (2026-2035) & (USD/KG)
Table 160. Global Live Brucellosis Vaccine Sales (K MT) Forecast by Application (2026-2035)
Table 161. Global Live Brucellosis Vaccine Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Live Brucellosis Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Live Brucellosis Vaccine Market Size (M USD), 2025-2035
Figure 5. Global Live Brucellosis Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global Live Brucellosis Vaccine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Live Brucellosis Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Live Brucellosis Vaccine Product Life Cycle
Figure 13. Live Brucellosis Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global Live Brucellosis Vaccine Revenue Share by Manufacturers in 2025
Figure 15. Live Brucellosis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Live Brucellosis Vaccine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Live Brucellosis Vaccine Revenue in 2025
Figure 18. Industry Chain Map of Live Brucellosis Vaccine
Figure 19. Global Live Brucellosis Vaccine Market PEST Analysis
Figure 20. Global Live Brucellosis Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Live Brucellosis Vaccine Market Share by Type
Figure 27. Sales Market Share of Live Brucellosis Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Live Brucellosis Vaccine by Type in 2025
Figure 29. Market Share of Live Brucellosis Vaccine by Type (2020-2025)
Figure 30. Market Share of Live Brucellosis Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Live Brucellosis Vaccine Market Share by Application
Figure 33. Global Live Brucellosis Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Live Brucellosis Vaccine Sales Market Share by Application in 2025
Figure 35. Global Live Brucellosis Vaccine Market Share by Application (2020-2025)
Figure 36. Global Live Brucellosis Vaccine Market Share by Application in 2025
Figure 37. Global Live Brucellosis Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Live Brucellosis Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Live Brucellosis Vaccine Market Size by Region (2020-2025)
Figure 40. North America Live Brucellosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Live Brucellosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Live Brucellosis Vaccine Sales Market Share by Country in 2024
Figure 43. North America Live Brucellosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Live Brucellosis Vaccine Market Size by Country in 2024
Figure 45. U.S. Live Brucellosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Live Brucellosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Live Brucellosis Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Live Brucellosis Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Live Brucellosis Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Live Brucellosis Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Live Brucellosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Live Brucellosis Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Live Brucellosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Live Brucellosis Vaccine Market Size by Country in 2024
Figure 55. Germany Live Brucellosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Live Brucellosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Live Brucellosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Live Brucellosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Live Brucellosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Live Brucellosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Live Brucellosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Live Brucellosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Live Brucellosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Live Brucellosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Live Brucellosis Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Live Brucellosis Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Live Brucellosis Vaccine Market Size by Region in 2024
Figure 68. China Live Brucellosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Live Brucellosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Live Brucellosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Live Brucellosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Live Brucellosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Live Brucellosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Live Brucellosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Live Brucellosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Live Brucellosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Live Brucellosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Live Brucellosis Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Live Brucellosis Vaccine Sales Market Share by Country in 2024
Figure 80. South America Live Brucellosis Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Live Brucellosis Vaccine Market Size by Country in 2024
Figure 82. Brazil Live Brucellosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Live Brucellosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Live Brucellosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Live Brucellosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Live Brucellosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Live Brucellosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Live Brucellosis Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Live Brucellosis Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Live Brucellosis Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Live Brucellosis Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia Live Brucellosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Live Brucellosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Live Brucellosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Live Brucellosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Live Brucellosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Live Brucellosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Live Brucellosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Live Brucellosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Live Brucellosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Live Brucellosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Live Brucellosis Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Live Brucellosis Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Live Brucellosis Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Live Brucellosis Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Live Brucellosis Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Live Brucellosis Vaccine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Live Brucellosis Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Live Brucellosis Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Live Brucellosis Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global Live Brucellosis Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global Live Brucellosis Vaccine Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Live Brucellosis Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Live Brucellosis Vaccine Market Size (M USD), 2025-2035
Figure 5. Global Live Brucellosis Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global Live Brucellosis Vaccine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Live Brucellosis Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Live Brucellosis Vaccine Product Life Cycle
Figure 13. Live Brucellosis Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global Live Brucellosis Vaccine Revenue Share by Manufacturers in 2025
Figure 15. Live Brucellosis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Live Brucellosis Vaccine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Live Brucellosis Vaccine Revenue in 2025
Figure 18. Industry Chain Map of Live Brucellosis Vaccine
Figure 19. Global Live Brucellosis Vaccine Market PEST Analysis
Figure 20. Global Live Brucellosis Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Live Brucellosis Vaccine Market Share by Type
Figure 27. Sales Market Share of Live Brucellosis Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Live Brucellosis Vaccine by Type in 2025
Figure 29. Market Share of Live Brucellosis Vaccine by Type (2020-2025)
Figure 30. Market Share of Live Brucellosis Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Live Brucellosis Vaccine Market Share by Application
Figure 33. Global Live Brucellosis Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Live Brucellosis Vaccine Sales Market Share by Application in 2025
Figure 35. Global Live Brucellosis Vaccine Market Share by Application (2020-2025)
Figure 36. Global Live Brucellosis Vaccine Market Share by Application in 2025
Figure 37. Global Live Brucellosis Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Live Brucellosis Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Live Brucellosis Vaccine Market Size by Region (2020-2025)
Figure 40. North America Live Brucellosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Live Brucellosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Live Brucellosis Vaccine Sales Market Share by Country in 2024
Figure 43. North America Live Brucellosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Live Brucellosis Vaccine Market Size by Country in 2024
Figure 45. U.S. Live Brucellosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Live Brucellosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Live Brucellosis Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Live Brucellosis Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Live Brucellosis Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Live Brucellosis Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Live Brucellosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Live Brucellosis Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Live Brucellosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Live Brucellosis Vaccine Market Size by Country in 2024
Figure 55. Germany Live Brucellosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Live Brucellosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Live Brucellosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Live Brucellosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Live Brucellosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Live Brucellosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Live Brucellosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Live Brucellosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Live Brucellosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Live Brucellosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Live Brucellosis Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Live Brucellosis Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Live Brucellosis Vaccine Market Size by Region in 2024
Figure 68. China Live Brucellosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Live Brucellosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Live Brucellosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Live Brucellosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Live Brucellosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Live Brucellosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Live Brucellosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Live Brucellosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Live Brucellosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Live Brucellosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Live Brucellosis Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Live Brucellosis Vaccine Sales Market Share by Country in 2024
Figure 80. South America Live Brucellosis Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Live Brucellosis Vaccine Market Size by Country in 2024
Figure 82. Brazil Live Brucellosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Live Brucellosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Live Brucellosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Live Brucellosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Live Brucellosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Live Brucellosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Live Brucellosis Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Live Brucellosis Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Live Brucellosis Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Live Brucellosis Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia Live Brucellosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Live Brucellosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Live Brucellosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Live Brucellosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Live Brucellosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Live Brucellosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Live Brucellosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Live Brucellosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Live Brucellosis Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Live Brucellosis Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Live Brucellosis Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Live Brucellosis Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Live Brucellosis Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Live Brucellosis Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Live Brucellosis Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Live Brucellosis Vaccine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Live Brucellosis Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Live Brucellosis Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Live Brucellosis Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global Live Brucellosis Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global Live Brucellosis Vaccine Market Share Forecast by Application (2026-2035)
